论文部分内容阅读
本文报告在综合疗法的基础上，应用促肝细胞生长素（ＰＨＧＰ）加小 剂量肝素治疗肝硬化 ６０咧（治疗组），以同期综合疗法的 ５０例肝硬化患者（对照 组）为对照，结果表明：１．治疗组在恢复肝功能、降低ＡＬＴ和ＳＢ、提高白蛋白、消 退和水，改善微循环方面均优于对照组；２．ＰＨＧＦ加小剂量肝素治疗肝硬化的总 有效率为８５％，对照组为 ６２％，两组间具有非常显著性差异（Ｐ＜０．００１）。方法简 便易行，安全可靠。
This article reports on the basis of the combination therapy, the application of hepatoblast growth factor (PHGP) plus a small dose of heparin in the treatment of cirrhosis 60 blanket (treatment group), the same period of 50 patients with cirrhosis (control group) as a control, the results Show: 1. The treatment group was better than the control group in restoring liver function, reducing ALT and SB, increasing albumin, dissipating and water, and improving microcirculation.2. The total effective rate of PHGF plus low-dose heparin in the treatment of cirrhosis was 85% in the control group and 62% in the control group, with a significant difference between the two groups (P <0.001). The method is simple, safe and reliable.